MarginsXMarginsX
Home › Markets › Health Care › TLSA

Tiziana Life Sciences Ltd. Common Shares (TLSA)

TLSA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.5762
+1.11% on the day
Market cap
$73.3M
Micro cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerTLSA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited Kingdom
IPO year2018
SEC CIK0001723069
SEC industry codePharmaceutical Preparations
Incorporated inBermuda

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
3.7 months
$4.0M cash at December 31, 2025
Share count, 1 year
+8.1%
2024-12-31 to 2025-12-31 · +17.8% over 3 years
Going-concern doubt
Yes
20-F filed May 1, 2026
Insider net buying, 12 months
$1.0M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Group's ability to continue as a going concern."
20-F 2026-05-01
Cash and burn$4.0M cash; operating cash flow -$3.2M a quarter.Report 2025-12-31
Shares outstanding120,507,401 (2025-12-31); 111,462,617 a year earlier; 102,272,614 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-01-22
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPKF Littlejohn LLP, London, United KingdomPCAOB Form AP 2026-05-08
Late filings, 12 months1 NT noticeNT 20-F 2026-04-30
Insider trades, 12 monthsBought $1.0M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed-$18.4M-$12.8M$4.0MNo debt tagsNeeds four quarters20-F 2026-05-01
FY 2024
2024-12-31
Not filed-$11.9M-$1.5M$3.7MNo debt tagsNeeds four quarters20-F/A 2025-05-08
FY 2023
2023-12-31
Not filed-$17.7M-$15.7M$1.2MNo debt tagsNeeds four quarters20-F/A 2025-05-08
FY 2022
2022-12-31
Not filed-$15.4M-$19.6M$18.1MNo debt tagsNeeds four quarters20-F/A 2025-05-08
FY 2021
2021-12-31
Not filed-$23.4M-$21.8M$42.2MNo debt tagsNeeds four quarters20-F 2024-05-10
FY 2020
2020-12-31
Not filed-$26.1M-$11.3M$65.8M$324KNeeds four quarters20-F/A 2023-06-13
FY 2019
2019-12-31
Not filed-$9.3M-$6.8M$200K$313KNeeds four quarters20-F 2022-05-23
FY 2018
2018-12-31
Not filed-$7.9M-$4.6M$5.3M$302KNeeds four quarters20-F 2021-05-17

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-01-22
Latest annual report
ANNUAL REPORT
20-F2026-05-01
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-11-12

Source: SEC EDGAR submissions feed, 496 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-17.4%
1 month-47.7%
3 months-45.2%
Year to date-61.7%
1 year-65.5%
From 52-week high-68.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
KALAKALA BIO Inc.$3.83-8.02%$74.1M
RANIRani Therapeutics Holdings Inc.$0.5403+2.66%$75.4M
VTVTvTv Therapeutics Inc.$17.69-10.16%$71.0M
COYACoya Therapeutics Inc.$3.00-4.15%$70.4M
CRBPCorbus Pharmaceuticals Holdings Inc.$3.38-0.44%$69.5M
CPIXCumberland Pharmaceuticals Inc.$5.21-11.39%$78.1M
MNOVMedicinova Inc$1.34-3.94%$68.7M
ZYBTZhengye Biotechnology Holding Limited$1.43-4.67%$67.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier